Antimicrobial peptides derived from Nemuri induce ribosomal condensation to inhibit translation

Authors:

Abstract
Antibiotic resistance is a global health threat requiring antimicrobials with alternative modes of action. Growing evidence indicates that bacteria organize key intracellular processes through biomolecular condensates and other forms of spatial organization, yet whether such spatial organization can be exploited as an antimicrobial target remains unclear. Here, we identify intrinsically disordered antimicrobial peptides, generated from the Drosophila sleep-inducing protein Nemuri, that inhibit bacterial growth by targeting ribosomal organization. Mechanistically, these peptides enter bacterial cells without overt membrane disruption and accumulate in ribosome-rich regions, where they bind broadly to RNA and ribosomal surfaces through multivalent interactions. This engagement remodels ribosome-rich regions into condensates with reduced ribosomal mobility, thereby suppressing global protein synthesis and distinguishing these peptides from canonical site-specific ribosome-targeting antibiotics. Furthermore, Nemuri-derived peptides exhibit broad-spectrum antimicrobial activity, including activity against drug-resistant pathogens, with low cytotoxicity toward Drosophila and mammalian cells. Together, our findings identify the organization and material dynamics of bacterial ribosomes as a biophysical vulnerability that can be exploited by antimicrobial peptides, revealing how a naturally evolved metazoan host-defense system turns intracellular organization itself into an antibacterial target.
Funding Information
  • Japan Society for the Promotion of Science (JP22H00411; JP20H03291; JP21H05133; JP24K02059)
  • Japan Society for the Promotion of Science (JP24KJ0004; JP24K18076)
  • Japan Society for the Promotion of Science (JP24K09392)
  • Japan Society for the Promotion of Science (JP21H05129; JP21H05130; JP24H02302)
  • Japan Society for the Promotion of Science (JP22H00411; JP23K20044; JP24H00060; JP25H01320; JP25H01321)
  • Japan Agency for Medical Research and Development (JP21zf0127005)
  • Japan Agency for Medical Research and Development (JP21zf0127005)
  • Japan Agency for Medical Research and Development (JP21wm0525011)
  • Japan Science and Technology Agency (JPMJPR22E8)
  • Japan Science and Technology Agency (JPMJPR22E5)
  • Japan Science and Technology Agency (JPMJPR21E1)
  • Japan Science and Technology Agency (JPMJPR20E5)
  • Inamori Foundation
  • Mitsubishi Foundation
  • Takeda Science Foundation
  • Core Research for Evolutional Science and Technology (JPMJCR20E3)

This publication has 103 references indexed in Scilit: